Brief: Aap Implantate sees FY 2016 sales of 13-15 million euros
02/05/2016 07:44
May 2 (Reuters) - Aap Implantate AG AAQG.DE :
* Said on Saturday sees FY 2016 sales of between 13.0
million and 15.0 million euros ($17.19 million) in the continued
operation with 20 pct growth in trauma products
* Sees FY 2016 EBITDA of between -5.5 million and -3.9
million euros for the continued operation
* Sees FY 2016 EDITDA of the Group (continued and
discontinued operation) incl. deconsolidation gain of between
14.1 million and 15.7 million euros
Source text for Eikon: urn:newsml:reuters.com:*:nHUG6YksTY
Further company coverage: AAQG.DE
($1 = 0.8724 euros)
(Gdynia Newsroom)
((Gdynia.newsroom@thomsonreuters.com; +48 58 698 3920;))
Recent news on aap Implantate AG
See all newsBrief: Aap Confirms Rubino Di Girolamo As CEO Through The End Of 2028 COO Agnieszka Mierzejewska Will Leave The Company At The End Of The Year
Brief: aap Implantate Says Postponement Of Publication Of Annual Financial Statements
Brief: Aap Implantate AG Says Increases Its EBITDA In 9M From - 1.6 Mln Euros To 0 Euros
Brief: aap Implantate Says Resumes Step-By-Step Restart Of It Systems
Brief: Aap Implantate Says Possible Cyber Attack On Co